In October 2018, the Trump Administration published a proposed health reimbursement arrangement rule that if finalized could pave the way for a tax-preferred defined contribution option that large employers could adopt to provide health care benefits to current employees.
In piece 5, we'll look at Medicare Extra for All, one of several potential reform proposals that would create a “public option” – a government-run plan that is made available to Americans as an alternative to existing private insurance.
This education piece presents a conceptual framework within which we can understand and evaluate proposals that are now (or will likely be) part of the coming discussions on health care reform among policy makers, think tanks and other stakeholders.
This piece provides a foundational overview of the key players in the US health care system, what makes our system unique compared to other countries, and the biggest problems facing the viability of the system.
The fundamental question regarding the establishment of a large-employer not-for-profit venture should not be “Can the model work?” but rather “How soon can it start benefiting my company and my employees?”
Plan sponsors have a common objective: to remain vigilant to make sure that they are getting the most for the dollars being spent on pharmaceuticals by themselves, their employees and dependents, and their retirees.
Despite the need for real health care transparency, many key health care industry stakeholders are resisting efforts to create the kind of full accountability that would drive lower costs and improved quality.
Faced with rising and unsustainable health costs, varying quality, and the uncertainty surrounding the implementation and impact of the Affordable Care Act, large employers must take specific steps in pursuit of a transparent health care market.